Dave Suchon
entrepreneurMale0.0Global Dominance: 0.00%
Dave Suchon is the co-founder, CEO, and director of Vimy Pharmaceuticals Inc., a company aimed at producing a made-in-Canada generic version of the diabetes drug Ozempic. With a background in law and biochemistry, he previously served as vice-president of corporate affairs at Novo Nordisk Canada, where he gained valuable experience in the pharmaceutical industry.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dave Suchon is the chief executive officer and co-founder of Vimy Pharma.
Ozempic maker cuts price as generic versions hit pharmacy shelvesThe Globe and Mail·
Canada· 2026-05-27
Canada· 2026-05-27
Dave Suchon, the chief executive officer of Vimy Pharma, aims to create a Canadian-made and Canadian-owned producer of generic semaglutide.
Canada will be a launching pad for the global race for generic OzempicThe Globe and Mail·Canada· 2026-01-30
Canada· 2026-01-30
Dave Suchon is the co-founder, CEO, and director of Vimy Pharma, aiming to produce a made-in-Canada version of Ozempic.
Canadian firm enters race to bring generic Ozempic to marketThe Globe and Mail·Canada· 2025-10-16
Canada· 2025-10-16
